CombiGene forms prominent Scientific Advisory Board within the pain program COZY (MFN)

Beskrivelse

Professor Lars Arendt-Nielsen, Head of Research at Aalborg University Hospital and Professor of Pain Research at Aalborg University, has been appointed to the Scientific Advisory Board of a joint project between CombiGene AB and Zyneyro ApS. The board, which includes two other world-leading experts in pain management, will provide critical scientific review and advice for the peptide project COZY01 and the gene therapy COZY02. These projects form part of the pain program COZY, which aims to develop effective treatments for chronic pain. (Summary provided by Infomedia) Kilder: Placera, 29-06-2023 Ipo Hub, 29-06-2023